PDF Archive

Easily share your PDF documents with your contacts, on the Web and Social Networks.

Share a file Manage my documents Convert Recover PDF Search Help Contact



Influenza Vaccines Market and Forecast .pdf



Original filename: Influenza Vaccines Market and Forecast.pdf
Title: Global Influenza Vaccines Market
Author: Publisher: iGATE Research

This PDF 1.5 document has been generated by Microsoft® Word 2016, and has been sent on pdf-archive.com on 26/02/2016 at 19:40, from IP address 163.53.x.x. The current document download page has been viewed 411 times.
File size: 593 KB (16 pages).
Privacy: public file




Download original PDF file









Document preview


© iGATE Research

Page 1 of 16

www.igateresearch.com

Global Influenza Vaccines Market - Overview
The influenza vaccine is one of the most lucrative segment of the global vaccines market.
Influenza is a highly communicable disease and typically has the most severe impact on children
and the elderly. Influenza viruses are considered as a major cause of morbidity and mortality
worldwide. The vast population base together with significantly low vaccination coverage in
emerging markets, rising government support for immunization and growing awareness of the
value of influenza vaccine in preventing disease are the prominent factors that will fuel the
growth of the influenza vaccines market.
In the influenza vaccines market, United States captures majority of the market share. Japan is
the second leading market for influenza vaccines with around XX% share in 2015. China and India
are the third and fourth leading market for influenza vaccines with XX% and XX% market share
respectively in 2015. Brazil, Germany, France, UK, Italy, Spain and South Korea are the other
leading market for influenza vaccines.
In the influenza vaccines brand sales segment, Sanofi’s Fluzone holds the maximum share of the
market being followed by Fluvirin/Flucelvax. GSK’s Fluarix/FluLaval accounts for the third
highest share of the influenza vaccines market. FluMist/Fluenz and Afluria/Fluvax stands at the
fourth and fifth position in the influenza vaccines market, while Flublok has captured least share
of the influenza vaccines market.
iGATE Research report titled “Influenza Vaccines Market and Forecast - Global Analysis”
provides a comprehensive analysis of the fast-evolving influenza vaccines market. This 176 Page
report contains 117 Figures and 8 Tables to present a clear picture of the influenza vaccines
market landscape.
The Influenza Vaccines Market have been analyzed from 4 viewpoints:
1. Influenza Vaccines Market, Persons Vaccinated and Forecast - Geographical
Distribution (2011 - 2021)
2. Global - Influenza Vaccines Brand Sales and Forecast to 2021
3. Global Influenza Vaccines Market - Major Deals
4. Global Influenza Vaccines Market - Driving Factors and Challenges

© iGATE Research

Page 2 of 16

www.igateresearch.com

Influenza Vaccines Market, Persons Vaccinated and Forecast - Geographical Distribution (25
Countries Covered)
1. United States
2. Canada
3. Brazil
4. Mexico
5. Germany
6. France
7. Italy
8. Spain
9. United Kingdom
10. Netherlands
11. Ireland
12. Denmark
13. Luxembourg
14. Sweden
15. Australia
16. New Zealand
17. Japan
18. China
19. India
20. South Korea
21. Singapore
22. Hong Kong
23. Malaysia
24. Thailand
25. Indonesia

© iGATE Research

Page 3 of 16

www.igateresearch.com

Global Influenza Vaccines Brand Sales and Forecast - 7 Brands Analyzed
1. Fluarix/FluLaval
2. Fluzone
3. Fluvirin/Flucelvax
4. Influvac
5. Afluria/Fluvax
6. FluMist/Fluenz
7. Flublok

© iGATE Research

Page 4 of 16

www.igateresearch.com

Table of Contents
1.

Executive Summary

2.

Global - Influenza Vaccines Market Analysis and Forecast (2011 - 2020)

3.

2.1

Global - Influenza Vaccines Market and Forecast (2011 - 2021)

2.2

Global - Number of Persons Vaccinated with Influenza Vaccines and Forecast (2011 - 2021)

Global - Influenza Vaccines Market Share Analysis and Forecast
3.1

Influenza Vaccines Market Share and Forecast - Country Wise Analysis (2011 - 2021)

3.2

Persons Being Vaccinated with Influenza Vaccines Share and Forecast - Country Wise Analysis

(2011 - 2021)

4.

Influenza Vaccines Market, Persons Vaccinated and Forecast - Geographical Distribution (2011

- 2021)
4.1

United States - Influenza Vaccines Market, Persons Vaccinated and Forecast

4.1.1

United States - Number of Persons Vaccinated with Influenza Vaccines and Forecast

4.1.2

United States - Influenza Vaccines Market and Forecast

4.2

Canada - Influenza Vaccines Market, Persons Vaccinated and Forecast

4.2.1

Canada - Number of Persons Vaccinated with Influenza Vaccines and Forecast

4.2.2

Canada - Influenza Vaccines Market and Forecast

4.3

Brazil - Influenza Vaccines Market, Persons Vaccinated and Forecast

4.3.1

Brazil - Number of Persons Vaccinated with Influenza Vaccines and Forecast

4.3.2

Brazil - Influenza Vaccines Market and Forecast

4.4

Mexico - Influenza Vaccines Market, Persons Vaccinated and Forecast

4.4.1

Mexico - Number of Persons Vaccinated with Influenza Vaccines and Forecast

4.4.2

Mexico - Influenza Vaccines Market and Forecast

4.5

Germany - Influenza Vaccines Market, Persons Vaccinated and Forecast

4.5.1

Germany - Number of Persons Vaccinated with Influenza Vaccines and Forecast

4.5.2

Germany - Influenza Vaccines Market and Forecast

4.6

France - Influenza Vaccines Market, Persons Vaccinated and Forecast

© iGATE Research

Page 5 of 16

www.igateresearch.com

4.6.1

France - Number of Persons Vaccinated with Influenza Vaccines and Forecast

4.6.2

France - Influenza Vaccines Market and Forecast

4.7

Italy - Influenza Vaccines Market, Persons Vaccinated and Forecast

4.7.1

Italy - Number of Persons Vaccinated with Influenza Vaccines and Forecast

4.7.2

Italy - Influenza Vaccines Market and Forecast

4.8

Spain - Influenza Vaccines Market, Persons Vaccinated and Forecast

4.8.1

Spain - Number of Persons Vaccinated with Influenza Vaccines and Forecast

4.8.2

Spain - Influenza Vaccines Market and Forecast

4.9

United Kingdom - Influenza Vaccines Market, Persons Vaccinated and Forecast

4.9.1

United Kingdom - Number of Persons Vaccinated with Influenza Vaccines and Forecast

4.9.2

United Kingdom - Influenza Vaccines Market and Forecast

4.10

Netherlands - Influenza Vaccines Market, Persons Vaccinated and Forecast

4.10.1

Netherlands - Number of Persons Vaccinated with Influenza Vaccines and Forecast

4.10.2

Netherlands - Influenza Vaccines Market and Forecast

4.11

Ireland - Influenza Vaccines Market, Persons Vaccinated and Forecast

4.11.1

Ireland - Number of Persons Vaccinated with Influenza Vaccines and Forecast

4.11.2

Ireland - Influenza Vaccines Market and Forecast

4.12

Denmark - Influenza Vaccines Market, Persons Vaccinated and Forecast

4.12.1

Denmark - Number of Persons Vaccinated with Influenza Vaccines and Forecast

4.12.2

Denmark - Influenza Vaccines Market and Forecast

4.13

Luxembourg - Influenza Vaccines Market, Persons Vaccinated and Forecast

4.13.1

Luxembourg - Number of Persons Vaccinated with Influenza Vaccines and Forecast

4.13.2

Luxembourg - Influenza Vaccines Market and Forecast

4.14

Sweden - Influenza Vaccines Market, Persons Vaccinated and Forecast

4.14.1

Sweden - Number of Persons Vaccinated with Influenza Vaccines and Forecast

4.14.2

Sweden - Influenza Vaccines Market and Forecast

4.15

Australia - Influenza Vaccines Market, Persons Vaccinated and Forecast

4.15.1

Australia - Number of Persons Vaccinated with Influenza Vaccines and Forecast

4.15.2

Australia - Influenza Vaccines Market and Forecast

4.16

New Zealand - Influenza Vaccines Market, Persons Vaccinated and Forecast

4.16.1

New Zealand - Number of Persons Vaccinated with Influenza Vaccines and Forecast

4.16.2

New Zealand - Influenza Vaccines Market and Forecast

4.17

Japan - Influenza Vaccines Market, Persons Vaccinated and Forecast

© iGATE Research

Page 6 of 16

www.igateresearch.com

4.17.1

Japan - Number of Persons Vaccinated with Influenza Vaccines and Forecast

4.17.2

Japan - Influenza Vaccines Market and Forecast

4.18

4.18.1

China - Number of Persons Vaccinated with Influenza Vaccines and Forecast

4.18.2

China - Influenza Vaccines Market and Forecast

4.19

India - Influenza Vaccines Market, Persons Vaccinated and Forecast

4.19.1

India - Number of Persons Vaccinated with Influenza Vaccines and Forecast

4.19.2

India - Influenza Vaccines Market and Forecast

4.20

South Korea - Influenza Vaccines Market, Persons Vaccinated and Forecast

4.20.1

South Korea - Number of Persons Vaccinated with Influenza Vaccines and Forecast

4.20.2

South Korea - Influenza Vaccines Market and Forecast

4.21

Thailand - Influenza Vaccines Market, Persons Vaccinated and Forecast

4.21.1

Thailand - Number of Persons Vaccinated with Influenza Vaccines and Forecast

4.21.2

Thailand - Influenza Vaccines Market and Forecast

4.22

Singapore - Influenza Vaccines Market, Persons Vaccinated and Forecast

4.22.1

Singapore - Number of Persons Vaccinated with Influenza Vaccines and Forecast

4.22.2

Singapore - Influenza Vaccines Market and Forecast

4.23

Hong Kong - Influenza Vaccines Market, Persons Vaccinated and Forecast

4.23.1

Hong Kong - Number of Persons Vaccinated with Influenza Vaccines and Forecast

4.23.2

Hong Kong - Influenza Vaccines Market and Forecast

4.24

Malaysia - Influenza Vaccines Market, Persons Vaccinated and Forecast

4.24.1

Malaysia - Number of Persons Vaccinated with Influenza Vaccines and Forecast

4.24.2

Malaysia - Influenza Vaccines Market and Forecast

4.25

5.

China - Influenza Vaccines Market, Persons Vaccinated and Forecast

Indonesia - Influenza Vaccines Market, Persons Vaccinated and Forecast

4.25.1

Indonesia - Number of Persons Vaccinated with Influenza Vaccines and Forecast

4.25.2

Indonesia - Influenza Vaccines Market and Forecast

Global - Influenza Vaccines Brand Sales and Forecast
5.1

Global - Fluarix / FluLaval Sales and Forecast (2007 - 2021)

5.2

Global - Fluzone Sales and Forecast (2009 - 2021)

5.3

Global - Fluvirin/Flucelvax Sales and Forecast (2010 - 2021)

5.4

Global - Influvac (Acquired by Abbott) Sales (2007 - 2009)

© iGATE Research

Page 7 of 16

www.igateresearch.com

6.

7.

8.

5.5

Global - Afluria/Fluvax Sales and Forecast (2010 - 2021)

5.6

Global - FluMist/Fluenz Sales and Forecast (2007 - 2021)

5.7

Global - Flublok Sales and Forecast (2013 - 2021)

Influenza Vaccines Market - Major Deals
6.1

Mergers and Acquisitions

6.2

Licensing Agreements

Global Influenza Vaccines Market - Driving Factors
7.1

Transformation of Vaccine Technologies

7.2

Vaccines most Cost Effective Means of Disease Prevention

7.3

Scientific & Technological Breakthroughs

7.4

Continuous Focus on Effective Communication Strategies

7.5

Increasing Awareness on Seasonal Influenza & Vaccination

Global Influenza Vaccines Market - Challenges
8.1

Complexity of Vaccine Development and Approval System Thwarts Product Development

8.1.1

Legal Obstacles

8.1.2

General Technical Barriers

8.1.3

Economic Barriers

8.1.4

Regulatory Barriers

8.2

Hurdles to Optimal use of Licensed Vaccines

8.2.1

Technical Obstacles

8.2.2

Economic obstacles

8.2.3

Cultural Obstacles

8.3

Barriers to New Entrants in the Vaccines Market

8.4

Reducing the Timeline for Vaccine Development

8.5

Challenges Faced by Healthcare Workers in Immunization

© iGATE Research

Page 8 of 16

www.igateresearch.com

List of Figures:

Figure 2-1: Global - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 2-2: Global - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 2-3: Global - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 2-4: Global - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 2021

Figure 4-1: United States - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 4-2: United States - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million),
2016 - 2021
Figure 4-3: United States - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 4-4: United States - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 4-5: Canada - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 4-6: Canada - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 2021
Figure 4-7: Canada - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 4-8: Canada - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 4-9: Brazil - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 4-10: Brazil - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 2021
Figure 4-11: Brazil - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 4-12: Brazil - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 4-13: Mexico - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 4-14: Mexico - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 2021
Figure 4-15: Mexico - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 4-16: Mexico - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 4-17: Germany - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 4-18: Germany - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016
- 2021
Figure 4-19: Germany - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 4-20: Germany - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 4-21: France - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015

© iGATE Research

Page 9 of 16

www.igateresearch.com


Related documents


PDF Document influenza vaccines market and forecast
PDF Document united states influenza vaccines market 2016 material
PDF Document united states pediatric vaccines market
PDF Document dpi research europe influenza vaccines market
PDF Document seasonal influenza vaccine market
PDF Document global influenza vaccine market


Related keywords